Next Article in Journal
Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
Previous Article in Journal
Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods
Open AccessArticle

Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice

1
College of Pharmacy, Mokpo National University, Muan-gun, Jeonnam 58554, Korea
2
College of Pharmacy, Gachon Institute of Pharmaceutical Science, Gachon University, Yeonsu-gu, Incheon 21999, Korea
3
Korea Mouse Metabolic Phenotyping Center (KMMPC), Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Yeonsu-gu, Incheon 21999, Korea
4
Ocean Science & Technology School, Korea Maritime and Ocean University, Yeongdo-gu, Busan 49112, Korea
5
Gachon Medical Research Institute, Gil Hospital, Namdong-gu, Incheon 21565, Korea
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Peer B. Jacobson
Mar. Drugs 2015, 13(11), 6866-6883; https://doi.org/10.3390/md13116866
Received: 16 September 2015 / Revised: 28 October 2015 / Accepted: 30 October 2015 / Published: 12 November 2015
Ecklonia cava (E. cava; CA) is an edible brown alga with beneficial effects in diabetes via regulation of various metabolic processes such as lipogenesis, lipolysis, inflammation, and the antioxidant defense system in liver and adipose tissue. We investigated the effect of the polyphenol-rich fraction of E. cava produced from Gijang (G-CA) on nonalcoholic fatty liver disease (NAFLD) in high-fat diet (HFD)-fed mice. C57BL6 mice were fed a HFD for six weeks and then the HFD group was administered 300 mg/kg of G-CA extracts by oral intubation for 10 weeks. Body weight, fat mass, and serum biochemical parameters were reduced by G-CA extract treatment. MRI/MRS analysis showed that liver fat and liver volume in HFD-induced obese mice were reduced by G-CA extract treatment. Further, we analyzed hepatic gene expression related to inflammation and lipid metabolism. The mRNA expression levels of inflammatory cytokines and hepatic lipogenesis-related genes were decreased in G-CA-treated HFD mice. The mRNA expression levels of cholesterol 7 alpha-hydroxylase 1 (CYP7A1), the key enzyme in bile acid synthesis, were dramatically increased by G-CA treatment in HFD mice. We suggest that G-CA treatment ameliorated hepatic steatosis by inhibiting inflammation and improving lipid metabolism. View Full-Text
Keywords: Ecklonia cava; hepatic steatosis; MRI; MRS; fatty liver; NAFLD Ecklonia cava; hepatic steatosis; MRI; MRS; fatty liver; NAFLD
Show Figures

Graphical abstract

MDPI and ACS Style

Park, E.-Y.; Choi, H.; Yoon, J.-Y.; Lee, I.-Y.; Seo, Y.; Moon, H.-S.; Hwang, J.-H.; Jun, H.-S. Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice. Mar. Drugs 2015, 13, 6866-6883.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop